Patent · US Active

Ophthalmologic compositions and use mode thereof

US9289399B2 · kind B2 · utility

0Cited by
3References
8Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 4, 2012
Grant dateMar 22, 2016
Priority date
Expiry dateJun 28, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P41/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention concerns a pharmaceutical composition characterized in that it contains a combination of a parasympatholytic agent, a sympathomimetic agent and a local anaesthetic. Such a composition may be injected into the anterior chamber of the eye before a cataract operation or instilled on the eye before laser treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.